HCC Biomarkers

AFP-L3 and DCP

μTASWako® i30
Automated Platform
microfluidic-based clinical immunoanalyzer

utaswako_i30

The μTASWako i30 is a commercially available microfluidic-based clinical immunoanalyzer for in vitro diagnostic use in the United States and Canada. The microfluidic technology minimizes instrument hands-on time while maximizing efficiency through integration and automation of clinical laboratory processes. Currently Wako is offering AFP-L3 and DCP tests on the μTASWako i30.

Performance Through Technology
Speed, Precision and Sensitivity

  • Nine minutes to first result, two minutes per subsequent result
  • Throughput: 25 results per hour
  • Superb analytical sensitivity
  • Accurate and precise performance

Optimized Workflow Design
Efficiency and Productivity

  • Up to six analyte measurements per sample
  • Random assay selection per sample
  • Short setup time - 10 minutes
  • Two-hour walk away time
  • Automated calibration and quality control
  • STAT capability
  • LIS integration capability
  • RFID tag enabled reagent tracking

Easy to Use
Convenience and Automation

  • Ready to use reagents
  • Intuitive touch panel operation
  • On-board refrigerated reagents
  • Easy access to consumables and waste
  • Minimal routine maintenance